Archer Investment Corp Has $1.41 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Archer Investment Corp raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,777 shares of the healthcare conglomerate’s stock after acquiring an additional 259 shares during the period. Archer Investment Corp’s holdings in UnitedHealth Group were worth $1,405,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the third quarter valued at $27,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $30,000. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter worth $37,000. Finally, Friedenthal Financial acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $51,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 1.9 %

Shares of NYSE UNH opened at $529.71 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business’s fifty day moving average price is $532.43 and its 200-day moving average price is $564.77. The stock has a market capitalization of $487.48 billion, a PE ratio of 34.17, a P/E/G ratio of 1.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on UNH shares. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. KeyCorp reissued an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens boosted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.